Indication | Oncology |
Status | CDMO Tech-transfer ongoing. |
Product Advantages | Handa is utilizing its ONCORE™ technology to develop improved versions of Oncology drug for reducing the risk associated with sever side effect and improve bioavailability. |
Potential Market | Oncology market value is $133 billion in 2017. |